43 Our studies using SaCas9 showed a trend toward VEGF-A suppression in vivo , although it did not reach statistical significance (p = 0.9).
← all excerpts
Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal Neovascularization.
1
—
—